西部制药服务 WST
$399.81 +$7.33 (+1.87%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $399.81 0.00%
开盘$389.62
昨收$392.48
当日区间$386.88 – $402.40
成交量625.9K
市值$27.85B
市盈率（TTM）44.9
股息率0.22%
财报
财报日平均波动±10.7%近16次财报
收涨次数6 / 1638% 的概率
最佳反应+22.8%
最差反应-38.2%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q3 | 29 Oct 2026 | Pre Market | ±8.6% | +3.23% | 符合区间 |
| 2026/Q2 | 23 Jul 2026 | Pre Market | ±9.3% | -0.82% | 符合区间 |
| 2026/Q1 | 23 Apr 2026 | Pre Market | ±10.2% | +12.86% | 超出定价预期 |
| 2025/Q4 | 12 Feb 2026 | Pre Market | ±10.3% | -1.04% | 符合区间 |
| 2025/Q3 | 23 Oct 2025 | Pre Market | ±11.1% | +10.92% | 符合区间 |
| 2025/Q2 | 24 Jul 2025 | Pre Market | ±12.7% | +22.78% | 超出定价预期 |
| 2025/Q1 | 24 Apr 2025 | Pre Market | ±13.7% | -3.48% | 符合区间 |
| 2024/Q4 | 13 Feb 2025 | Pre Market | ±9.3% | -38.22% | 超出定价预期 |
| 2024/Q3 | 24 Oct 2024 | Pre Market | ±12.0% | +15.43% | 超出定价预期 |
| 2024/Q2 | 25 Jul 2024 | Pre Market | ±9.5% | -14.40% | 超出定价预期 |
| 2024/Q1 | 25 Apr 2024 | Pre Market | ±7.5% | -4.55% | 符合区间 |
| 2023/Q4 | 15 Feb 2024 | Pre Market | ±6.3% | -14.08% | 超出定价预期 |
| 2023/Q3 | 26 Oct 2023 | Pre Market | ±8.2% | -8.57% | 超出定价预期 |
| 2023/Q2 | 27 Jul 2023 | Pre Market | ±6.8% | -6.46% | 符合区间 |
| 2023/Q1 | 27 Apr 2023 | Pre Market | ±8.9% | -0.56% | 符合区间 |
| 2022/Q4 | 16 Feb 2023 | Pre Market | ±6.7% | +14.54% | 超出定价预期 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
营收构成
2026/Q2 季度
按业务线
基本面
最新报告季度：Q2, ended Jun 2026
营收$872.30M+13.8% YoY
营业利润$191.90M+20.8% YoY
净利润$154.00M+16.8% YoY
摊薄每股收益$2.15+18.1% YoY
自由现金流$80.80M-20.7% YoY
经营现金流$124.00M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率36.8%
营业利润率21.7%
净利率17.0%
净资产收益率19.1%
资产收益率14.1%
投入资本回报率16.9%
流动比率2.82
负债/资产比率26.6%
现金及投资$435.80M
总负债$291.20M
净现金（净负债）$144.60M
自由现金流/营收13.1%
暂无评论——快来第一个聊聊 WST。